• 800 343 7475ir@bio-techne.com bio-techne.com

    • Overview
    • News / Events
    • Company Information
    • Strategy
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    Navigation

      News / Events

    • Overview
    • News / Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Profile
      • Presentations
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
      • Annual Reports
    • Stock Data
      • Overview
      • Quote
      • Charts
      • Historical Data
    • SEC Filings
      • Overview
      • All SEC Filings
      • 10-K Filings
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents

    Press Releases

    • News / Events

    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    Oct 7, 2024

    ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff

    Sep 26, 2024

    LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH

    Sep 24, 2024

    BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING

    Sep 18, 2024

    ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape

    Sep 18, 2024

    BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT

    Sep 17, 2024

    ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics

    Sep 16, 2024

    ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies

    Aug 27, 2024

    ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine

    Aug 26, 2024

    BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES

    Aug 7, 2024

    BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS

    RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...49
    • Email Alerts
    • Contacts
    • RSS News Feed
    Bio-Techne

    614 McKinley Place NE
    Minneapolis, MN 55413
    USA

    TEL 612 379 2956
    Toll-free 800 343 7475
    FAX 612 656 4400

    Who We Are

    • About Bio-Techne
    • Bio-Techne Brands
    • Careers
    • Corporate & Social Responsibility
    • Terms and Conditions

    Investor Relations

    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance

    Stay Connected

    • Facebook Twitter LinkedIn YouTube Instagram
    • Contact Us

    Utility Footer Menu

    • Privacy and Cookie Policy
    • Site Map
    • © Copyright 2025 Bio-Techne. All Rights Reserved.